Characteristics and Survival of Korean Patients With Colorectal Cancer Based on Data From the Korea Central Cancer Registry Data

Overview

Journal Ann Coloproctol

Date 2018 Sep 14

PMID 30208684

Citations 22

Authors

Hyuk Hur

Chang-Mo Oh

Young-Joo Won

Jae Hwan Oh

Nam Kyu Kim

Affiliations

Soon will be listed here.

Abstract

Purpose: The incidence of colorectal cancer (CRC) in Korea has increased remarkably during the past few decades. The present study investigated the characteristics and survival of patients with CRC in Korea as a function of time, tumor distribution, stage, sex, and age.

Methods: We retrieved clinical data on 326,712 CRC patients diagnosed between 1996 and 2015 from the Korea Central Cancer Registry. The incidence and the 5-year relative survival rates were compared across time period, tumor distribution, stage, sex, and age group.

Results: The percentage of patients with colon cancer increased from 49.5% in 1996-2000 to 66.4% in 2011-2015 while the percentage of patients with rectal cancer decreased from 50.5% to 33.6%. The 5-year relative survival rates for all CRCs improved from 58.7% in 1996-2000 to 75.0% in 2011-2015. For 1996-2000, survival rates were highest for patients with left-sided colon cancers, followed by those with right-sided, transverse, rectal, rectosigmoid cancers. For 2011-2015, the survival rates for patients with left-sided cancers were highest, followed by those with rectosigmoid, rectal, transverse, and right-sided colon cancers. Patients with local and regional, but not distant, SEER (Surveillance, Epidemiology, and End Results) stage tumors experienced significantly increased survival rates for 2006-2010 and 2011-2015. The proportion of CRC patients by age decreased in the order ≥70, 60-69, 50-59, 40-49, ≤39 years whereas survival rates decreased in the order 50-59, 60-69, 40-49, ≤39, ≥70 years.

Conclusion: Korean CRC has some distinct characteristics and survival patterns in terms of tumor distribution, stage, sex, and age. With time, survival outcomes have improved for both local and regional, but not distant, stage tumors.

Citing Articles

Impact of Small Area Level Deprivation on Colorectal Cancer Survival: Findings from the Regional Cancer Registry in Korea.

Hong S, Kim A, Kim C, Jang S, Kim D, Baek D Cancers (Basel). 2025; 17(4).

PMID: 40002161 PMC: 11852685. DOI: 10.3390/cancers17040567.

Standardized Mortality Ratios (SMRs) and Radon Exposure Analysis for Lung Cancer and All-Cause Mortality in Locorotondo, Southern Italy.

Ferri G, De Maria L, Delvecchio G, Caputi A, Sole S, Giannelli G Medicina (Kaunas). 2025; 61(1).

PMID: 39859029 PMC: 11766524. DOI: 10.3390/medicina61010047.

Essential knowledge and technical tips for total mesorectal excision and related procedures for rectal cancer.

Cho M, Bae H, Kim N Ann Coloproctol. 2024; 40(4):384-411.

PMID: 39228201 PMC: 11375228. DOI: 10.3393/ac.2024.00388.0055.

Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis.

Jun S, Cho S, Kim M, Park J, Ryoo S, Jeong S Cancer Med. 2024; 13(5):e7084.

PMID: 38477501 PMC: 10935880. DOI: 10.1002/cam4.7084.

Colorectal cancer in adolescent and young adults: epidemiology in Japan and narrative review.

Ueno A, Yokota M, Ueno M, Kawamoto K J Gastrointest Oncol. 2023; 14(4):1856-1868.

PMID: 37720434 PMC: 10502560. DOI: 10.21037/jgo-23-98.

References

Allemani C, Weir H, Carreira H, Harewood R, Spika D, Wang X . Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2014; 385(9972):977-1010. PMC: 4588097. DOI: 10.1016/S0140-6736(14)62038-9. View

Siegel R, Miller K, Fedewa S, Ahnen D, Meester R, Barzi A . Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017; 67(3):177-193. DOI: 10.3322/caac.21395. View

Paulson E, Wirtalla C, Armstrong K, Mahmoud N . Gender influences treatment and survival in colorectal cancer surgery. Dis Colon Rectum. 2009; 52(12):1982-91. DOI: 10.1007/DCR.0b013e3181beb42a. View

Shin A, Joo J, Bak J, Yang H, Kim J, Park S . Site-specific risk factors for colorectal cancer in a Korean population. PLoS One. 2011; 6(8):e23196. PMC: 3154290. DOI: 10.1371/journal.pone.0023196. View

Singh H, Demers A, Xue L, Turner D, Bernstein C . Time trends in colon cancer incidence and distribution and lower gastrointestinal endoscopy utilization in Manitoba. Am J Gastroenterol. 2008; 103(5):1249-56. DOI: 10.1111/j.1572-0241.2007.01726.x. View

Lan Y, Jen-Kou L, Lin C, Yang S, Lin C, Wang H . Mutations in the RAS and PI3K pathways are associated with metastatic location in colorectal cancers. J Surg Oncol. 2015; 111(7):905-10. DOI: 10.1002/jso.23895. View

Heald R, Husband E, Ryall R . The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?. Br J Surg. 1982; 69(10):613-6. DOI: 10.1002/bjs.1800691019. View

Shen H, Yang J, Huang Q, Jiang M, Tan Y, Fu J . Different treatment strategies and molecular features between right-sided and left-sided colon cancers. World J Gastroenterol. 2015; 21(21):6470-8. PMC: 4458758. DOI: 10.3748/wjg.v21.i21.6470. View

Chung S, Kim Y, Yang S, Song J, Park M, Kim J . Prevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40-49 years undergoing screening colonoscopy. J Gastroenterol Hepatol. 2010; 25(3):519-25. DOI: 10.1111/j.1440-1746.2009.06147.x. View

10.

Kontou N, Psaltopoulou T, Soupos N, Polychronopoulos E, Xinopoulos D, Linos A . Alcohol consumption and colorectal cancer in a Mediterranean population: a case-control study. Dis Colon Rectum. 2012; 55(6):703-10. DOI: 10.1097/DCR.0b013e31824e612a. View

11.

Shin A, Kim K, Jung K, Park S, Won Y, Kim J . Increasing trend of colorectal cancer incidence in Korea, 1999-2009. Cancer Res Treat. 2013; 44(4):219-26. PMC: 3546268. DOI: 10.4143/crt.2012.44.4.219. View

12.

Hendifar A, Yang D, Lenz F, Lurje G, Pohl A, Lenz C . Gender disparities in metastatic colorectal cancer survival. Clin Cancer Res. 2009; 15(20):6391-7. PMC: 2779768. DOI: 10.1158/1078-0432.CCR-09-0877. View

13.

Park H, Woo H, Jung S, Jung K, Shin H, Shin A . Colorectal cancer incidence in 5 Asian countries by subsite: An analysis of Cancer Incidence in Five Continents (1998-2007). Cancer Epidemiol. 2016; 45:65-70. DOI: 10.1016/j.canep.2016.09.012. View

14.

Jung K, Won Y, Kong H, Lee E . Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015. Cancer Res Treat. 2018; 50(2):303-316. PMC: 5912151. DOI: 10.4143/crt.2018.143. View

15.

Weiss J, Pfau P, OConnor E, King J, LoConte N, Kennedy G . Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results--Medicare data. J Clin Oncol. 2011; 29(33):4401-9. PMC: 3221523. DOI: 10.1200/JCO.2011.36.4414. View

16.

Park H, Shin A, Kim B, Jung K, Won Y, Oh J . Data on the characteristics and the survival of korean patients with colorectal cancer from the Korea central cancer registry. Ann Coloproctol. 2013; 29(4):144-9. PMC: 3767863. DOI: 10.3393/ac.2013.29.4.144. View

17.

Larsen I, Bray F . Trends in colorectal cancer incidence in Norway 1962-2006: an interpretation of the temporal patterns by anatomic subsite. Int J Cancer. 2009; 126(3):721-32. DOI: 10.1002/ijc.24839. View

18.

Leff D, Chen A, Roberts D, Grant K, Western C, Windsor A . Colorectal cancer in the young patient. Am Surg. 2007; 73(1):42-7. View

19.

Lee M, Mcguffey E, Morris J, Manyam G, Baladandayuthapani V, Wei W . Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer. Br J Cancer. 2016; 114(12):1352-61. PMC: 4984478. DOI: 10.1038/bjc.2016.87. View

20.

Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R . Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004; 351(17):1731-40. DOI: 10.1056/NEJMoa040694. View